What is Pitney Bowes's earnings per share (EPS)?

Pitney Bowes (PBI) reported diluted earnings per share of $0.84 for fiscal year 2025. This represents a 175.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Pitney Bowes Financials

PBI

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Pitney Bowes (PBI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PBI FY2025 2026-05-06

Pitney Bowes’ main operating shift is cash extraction from a shrinking revenue base, while the balance sheet stays tight.

From FY2023 to FY2025, revenue slipped from $2.08B to $1.89B, so the cash rebound did not come from renewed scale. Over the same span, operating cash flow rose from $80.1M to $383.3M as SG&A was cut sharply, meaning the business has been resized to pull more cash from each remaining sales dollar.

The balance sheet is still liability-led: FY2025 ended with $284.9M of cash against $2.0B of long-term debt, so better cash generation has not translated into a larger financial cushion. A current ratio of 0.7x reinforces that short-term flexibility is tighter than the stronger cash-flow line alone would imply, with negative equity still in place.

FY2025’s earnings quality looks better than FY2024 because free cash flow reached $317.0M versus net income of $144.7M, so the return to profit was backed by cash rather than accounting alone. But that cash was largely redeployed, with $378.4M of buybacks helping pull year-end cash lower instead of rebuilding liquidity.

Financial Health Signals

Financial Profile 14/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Pitney Bowes's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Pitney Bowes's revenue declined 6.6% year-over-year, from $2.0B to $1.9B. This contraction results in a growth score of 26/100.

Leverage

Pitney Bowes has elevated debt relative to equity (D/E of -2.46), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Pitney Bowes's current ratio of 0.71 is below the typical benchmark, resulting in a score of 9/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Pitney Bowes has a free cash flow margin of 16.8%, earning a moderate score of 52/100. The company generates positive cash flow after capital investments, but with room for improvement.

Piotroski F-Score Neutral

6/9

Pitney Bowes passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.65x

For every $1 of reported earnings, Pitney Bowes generates $2.65 in operating cash flow ($383.3M OCF vs $144.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.9B

YoY-6.6%

5Y CAGR-11.8%

10Y CAGR-6.2%

Pitney Bowes generated $1.9B in revenue in fiscal year 2025. This represents a decrease of 6.6% from the prior year.

EBITDA

N/A

Net Income

$144.7M

YoY+171.1%

10Y CAGR-9.8%

Pitney Bowes reported $144.7M in net income in fiscal year 2025. This represents an increase of 171.1% from the prior year.

EPS (Diluted)

$0.84

YoY+175.0%

10Y CAGR-8.4%

Pitney Bowes earned $0.84 per diluted share (EPS) in fiscal year 2025. This represents an increase of 175.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$317.0M

YoY+102.2%

5Y CAGR+10.0%

10Y CAGR-1.2%

Pitney Bowes generated $317.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 102.2% from the prior year.

Cash & Debt

$284.9M

YoY-39.4%

5Y CAGR-20.9%

10Y CAGR-7.8%

Pitney Bowes held $284.9M in cash against $2.0B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.30

YoY+50.0%

5Y CAGR+8.4%

10Y CAGR-8.8%

Pitney Bowes paid $0.30 per share in dividends in fiscal year 2025. This represents an increase of 50.0% from the prior year.

Shares Outstanding

150M

YoY-18.0%

5Y CAGR-2.9%

Pitney Bowes had 150M shares outstanding in fiscal year 2025. This represents a decrease of 18.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

7.6%

YoY+17.7pp

5Y CAGR+12.7pp

10Y CAGR-3.8pp

Pitney Bowes's net profit margin was 7.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 17.7 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$15.3M

YoY-52.2%

5Y CAGR-16.8%

10Y CAGR-17.9%

Pitney Bowes invested $15.3M in research and development in fiscal year 2025. This represents a decrease of 52.2% from the prior year.

Share Buybacks

$378.4M

10Y CAGR+11.1%

Pitney Bowes spent $378.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$66.3M

YoY-8.5%

5Y CAGR-8.8%

10Y CAGR-8.8%

Pitney Bowes invested $66.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 8.5% from the prior year.

PBI Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.9B-6.6%	$2.0B-2.5%	$2.1B-16.3%	$2.5B-32.4%	$3.7B+3.4%	$3.6B
Cost of Revenue	N/A	$964.3M-8.0%	$1.0B	N/A	$2.6B+6.1%	$2.4B
Gross Profit	N/A	$1.1B+3.1%	$1.0B	N/A	$1.1B-2.4%	$1.1B
R&D Expenses	$15.3M-52.2%	$32.0M+8.4%	$29.5M-16.9%	$35.5M-24.2%	$46.8M+21.9%	$38.4M
SG&A Expenses	$621.6M-13.4%	$717.9M-8.2%	$781.6M-0.5%	$785.5M-15.0%	$924.2M-4.1%	$963.3M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$101.5M-192.2%	$110.1M+9.6%	$100.4M+11.6%	$90.0M-7.1%	$96.9M-8.4%	$105.8M
Income Tax	$47.8M+130.9%	-$154.8M-992.5%	$17.3M-59.6%	$43.0M+493.3%	-$10.9M-253.4%	$7.1M
Net Income	$144.7M+171.1%	-$203.6M+47.2%	-$385.6M-1143.9%	$36.9M+2834.3%	-$1.4M+99.3%	-$180.4M
EPS (Diluted)	$0.84+175.0%	$-1.12+49.1%	$-2.20-1147.6%	$0.21+2200.0%	$-0.01+99.0%	$-1.05

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$477.4M0.0%	$477.6M+3.9%	$459.7M-0.5%	$461.9M-6.4%	$493.4M-4.4%	$516.1M+3.3%	$499.5M+2.0%	$489.7M
Cost of Revenue	$156.2M	N/A	N/A	N/A	N/A	$238.5M+0.2%	$238.0M-0.5%	$239.3M
Gross Profit	$150.4M	N/A	N/A	N/A	N/A	$277.6M+6.2%	$261.5M+4.4%	$250.5M
R&D Expenses	$3.8M+8.2%	$3.5M+2.8%	$3.4M-5.3%	$3.6M-24.4%	$4.8M	N/A	$7.6M+4.4%	$7.3M
SG&A Expenses	$133.4M-5.4%	$141.0M-2.2%	$144.2M-15.5%	$170.5M+2.8%	$165.9M	N/A	$190.0M-1.5%	$192.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$26.0M+0.7%	-$26.2M-0.4%	-$26.1M-4.6%	-$24.9M-2.7%	-$24.3M	N/A	$27.8M-3.5%	$28.8M
Income Tax	$22.3M+102.3%	$11.0M-31.8%	$16.2M+74.1%	$9.3M-17.8%	$11.3M+284.4%	-$6.1M+96.3%	-$166.5M-7430.1%	$2.3M
Net Income	$58.1M+112.7%	$27.3M-47.4%	$52.0M+73.4%	$30.0M-15.4%	$35.4M+194.8%	-$37.4M+73.0%	-$138.5M-456.9%	-$24.9M
EPS (Diluted)	$0.39	N/A	$0.30+76.5%	$0.17-10.5%	$0.19+190.5%	$-0.21+72.0%	$-0.75-435.7%	$-0.14

PBI Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.2B-6.7%	$3.4B-20.5%	$4.3B-9.9%	$4.7B-4.4%	$5.0B-5.1%	$5.2B
Current Assets	$1.1B-16.5%	$1.3B-36.0%	$2.1B+14.5%	$1.8B-5.0%	$1.9B-10.4%	$2.1B
Cash & Equivalents	$284.9M-39.4%	$469.7M-21.7%	$600.1M-10.2%	$668.3M-8.8%	$732.5M-20.5%	$921.5M
Inventory	$66.2M+10.7%	$59.8M-5.1%	$63.0M-24.7%	$83.7M+6.5%	$78.6M+9.9%	$71.5M
Accounts Receivable	$168.1M+5.1%	$160.0M-20.1%	$200.2M-41.7%	$343.6M+2.7%	$334.6M-14.0%	$389.2M
Goodwill	$746.7M+3.6%	$721.0M-1.8%	$734.4M-13.7%	$851.3M-25.0%	$1.1B-1.5%	$1.2B
Total Liabilities	$4.0B-0.1%	$4.0B-14.3%	$4.6B-0.9%	$4.7B-3.4%	$4.8B-6.0%	$5.2B
Current Liabilities	$1.5B-7.5%	$1.7B-11.9%	$1.9B+9.9%	$1.7B0.0%	$1.7B-7.6%	$1.9B
Long-Term Debt	$2.0B+5.9%	$1.9B-10.6%	$2.1B-3.9%	$2.2B-5.5%	$2.3B-2.1%	$2.3B
Total Equity	-$802.4M-38.7%	-$578.4M-56.9%	-$368.6M-707.7%	$60.7M-46.1%	$112.6M+59.5%	$70.6M
Retained Earnings	$2.7B-0.6%	$2.7B-13.2%	$3.1B-39.9%	$5.1B-0.8%	$5.2B-0.7%	$5.2B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$3.1B-0.7%	$3.2B-2.6%	$3.3B+0.5%	$3.2B-0.9%	$3.3B-3.8%	$3.4B-6.9%	$3.6B-10.6%	$4.1B
Current Assets	$1.1B+2.6%	$1.1B-4.3%	$1.1B+2.1%	$1.1B-5.0%	$1.2B-10.1%	$1.3B-11.3%	$1.5B-7.4%	$1.6B
Cash & Equivalents	$302.9M+6.3%	$284.9M-11.2%	$321.0M+12.6%	$285.2M-11.9%	$323.8M-31.1%	$469.7M-16.4%	$561.5M-4.8%	$590.1M
Inventory	$62.6M-5.5%	$66.2M-12.5%	$75.7M-4.2%	$79.0M+21.3%	$65.1M+8.8%	$59.8M-16.5%	$71.6M-6.4%	$76.5M
Accounts Receivable	$158.6M-5.7%	$168.1M+4.0%	$161.7M+4.1%	$155.3M-3.1%	$160.3M+0.2%	$160.0M-15.3%	$188.8M-29.1%	$266.2M
Goodwill	$742.9M-0.5%	$746.7M0.0%	$746.5M-0.3%	$748.5M+2.6%	$729.7M+1.2%	$721.0M-2.2%	$737.3M+1.3%	$727.6M
Total Liabilities	$4.0B+1.8%	$4.0B+1.4%	$3.9B+3.7%	$3.8B-0.8%	$3.8B-4.3%	$4.0B-4.6%	$4.2B-7.5%	$4.5B
Current Liabilities	$1.8B+17.5%	$1.5B+8.9%	$1.4B-4.5%	$1.5B0.0%	$1.5B-11.0%	$1.7B-0.7%	$1.7B+0.4%	$1.7B
Long-Term Debt	$1.8B-10.2%	$2.0B-5.4%	$2.1B+11.0%	$1.9B-0.9%	$1.9B+1.7%	$1.9B-9.1%	$2.1B-0.6%	$2.1B
Total Equity	-$893.6M-11.4%	-$802.4M-21.3%	-$661.5M-23.2%	-$536.8M-0.2%	-$535.9M+7.4%	-$578.4M-11.5%	-$518.9M-21.3%	-$427.9M
Retained Earnings	$2.7B+1.3%	$2.7B0.0%	$2.7B-0.5%	$2.7B+0.7%	$2.7B-0.8%	$2.7B-2.8%	$2.7B-6.8%	$2.9B

PBI Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$383.3M+67.2%	$229.2M+186.1%	$80.1M-54.2%	$175.0M-41.9%	$301.5M-0.2%	$302.0M
Capital Expenditures	$66.3M-8.5%	$72.4M-7.3%	$78.1M-5.5%	$82.6M-55.1%	$184.0M+75.3%	$105.0M
Free Cash Flow	$317.0M+102.2%	$156.8M+7809.5%	$2.0M-97.9%	$92.4M-21.3%	$117.5M-40.4%	$197.0M
Investing Cash Flow	-$125.1M-155.0%	-$49.1M+60.5%	-$124.1M-411.3%	-$24.3M+84.4%	-$155.3M-105.1%	-$75.7M
Financing Cash Flow	-$445.4M-45.8%	-$305.5M-918.1%	-$30.0M+84.9%	-$198.1M+40.0%	-$330.4M-40.4%	-$235.4M
Dividends Paid	$51.1M+42.0%	$36.0M+2.1%	$35.2M+1.4%	$34.7M-0.2%	$34.8M+1.5%	$34.3M
Share Buybacks	$378.4M	$0	$0-100.0%	$13.4M	$0	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$44.2M-80.1%	$221.7M+231.6%	$66.8M-40.0%	$111.4M+767.8%	-$16.7M-112.4%	$134.5M+812.0%	$14.7M-84.1%	$92.6M
Capital Expenditures	$15.8M-21.8%	$20.3M+28.2%	$15.8M+18.4%	$13.3M-21.0%	$16.9M-23.9%	$22.2M+14.1%	$19.4M+18.1%	$16.5M
Free Cash Flow	$28.3M-85.9%	$201.4M+294.6%	$51.1M-47.9%	$98.0M+392.1%	-$33.6M-129.9%	$112.3M+2493.4%	-$4.7M-106.2%	$76.1M
Investing Cash Flow	-$9.3M+36.2%	-$14.6M+60.0%	-$36.4M-27.5%	-$28.6M+37.3%	-$45.5M-363.3%	$17.3M+144.8%	-$38.6M-143.4%	-$15.9M
Financing Cash Flow	-$16.4M+93.2%	-$243.0M-4079.9%	$6.1M+104.9%	-$123.4M-45.1%	-$85.1M+64.2%	-$237.4M-3191.3%	-$7.2M-203.9%	-$2.4M
Dividends Paid	$13.3M-5.9%	$14.2M+6.4%	$13.3M+5.3%	$12.6M+15.0%	$11.0M+20.5%	$9.1M+0.5%	$9.1M+1.2%	$9.0M
Share Buybacks	$135.6M+7.2%	$126.6M-21.6%	$161.5M+114.5%	$75.3M+401.8%	$15.0M	$0	$0	$0

PBI Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	52.4%+2.9pp	49.6%	N/A	30.5%-1.8pp	32.3%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	7.6%+17.7pp	-10.1%+8.5pp	-18.6%-20.0pp	1.5%+1.5pp	-0.0%+5.0pp	-5.1%
Return on Equity	N/A	N/A	N/A	60.9%+62.1pp	-1.2%+254.2pp	-255.4%
Return on Assets	4.6%+10.6pp	-6.0%+3.0pp	-9.0%-9.8pp	0.8%+0.8pp	-0.0%+3.4pp	-3.5%
Current Ratio	0.71-0.1	0.79-0.3	1.08+0.0	1.04-0.1	1.09-0.0	1.13
Debt-to-Equity	-2.46+0.8	-3.23+2.4	-5.66-41.5	35.82+15.4	20.41-12.8	33.25
FCF Margin	16.8%+9.0pp	7.7%+7.6pp	0.1%-3.6pp	3.7%+0.5pp	3.2%-2.3pp	5.5%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	49.1%	N/A	N/A	N/A	N/A	53.8%+1.4pp	52.3%+1.2pp	51.1%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	12.2%+6.5pp	5.7%-5.6pp	11.3%+4.8pp	6.5%-0.7pp	7.2%+14.4pp	-7.2%+20.5pp	-27.7%-22.6pp	-5.1%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	1.8%+1.0pp	0.9%-0.7pp	1.6%+0.7pp	0.9%-0.2pp	1.1%+2.2pp	-1.1%+2.7pp	-3.8%-3.2pp	-0.6%
Current Ratio	0.62-0.1	0.71-0.1	0.81+0.1	0.76-0.0	0.800.0	0.79-0.1	0.88-0.1	0.96
Debt-to-Equity	-1.99+0.5	-2.46+0.7	-3.16+0.3	-3.51+0.0	-3.54-0.3	-3.23+0.7	-3.96+0.9	-4.83
FCF Margin	5.9%-36.3pp	42.2%+31.1pp	11.1%-10.1pp	21.2%+28.0pp	-6.8%-28.6pp	21.8%+22.7pp	-0.9%-16.5pp	15.5%

Note: Shareholder equity is negative (-$802.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.71), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Hub Group Inc HUBG

$2.6B

Forward Air FWRD

$339.4M

Radiant Logistic RLGT

$369.5M

Cryoport Inc CYRX

$663.8M

Gxo Logistics Incorporated GXO

$5.8B

Frequently Asked Questions

What is Pitney Bowes's annual revenue?

Pitney Bowes (PBI) reported $1.9B in total revenue for fiscal year 2025. This represents a -6.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Pitney Bowes's revenue growing?

Pitney Bowes (PBI) revenue declined by 6.6% year-over-year, from $2.0B to $1.9B in fiscal year 2025.

Is Pitney Bowes profitable?

Yes, Pitney Bowes (PBI) reported a net income of $144.7M in fiscal year 2025, with a net profit margin of 7.6%.

How much debt does Pitney Bowes have?

As of fiscal year 2025, Pitney Bowes (PBI) had $284.9M in cash and equivalents against $2.0B in long-term debt.

What is Pitney Bowes's net profit margin?

Pitney Bowes (PBI) had a net profit margin of 7.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Pitney Bowes pay dividends?

Yes, Pitney Bowes (PBI) paid $0.30 per share in dividends during fiscal year 2025.

What is Pitney Bowes's free cash flow?

Pitney Bowes (PBI) generated $317.0M in free cash flow during fiscal year 2025. This represents a 102.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Pitney Bowes's operating cash flow?

Pitney Bowes (PBI) generated $383.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Pitney Bowes's total assets?

Pitney Bowes (PBI) had $3.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Pitney Bowes's capital expenditures?

Pitney Bowes (PBI) invested $66.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Pitney Bowes spend on research and development?

Pitney Bowes (PBI) invested $15.3M in research and development during fiscal year 2025.

Does Pitney Bowes buy back shares?

Yes, Pitney Bowes (PBI) spent $378.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Pitney Bowes have outstanding?

Pitney Bowes (PBI) had 150M shares outstanding as of fiscal year 2025.

What is Pitney Bowes's current ratio?

Pitney Bowes (PBI) had a current ratio of 0.71 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Pitney Bowes's debt-to-equity ratio?

Pitney Bowes (PBI) had a debt-to-equity ratio of -2.46 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Pitney Bowes's return on assets (ROA)?

Pitney Bowes (PBI) had a return on assets of 4.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Pitney Bowes's debt-to-equity ratio negative or unusual?

Pitney Bowes (PBI) has negative shareholder equity of -$802.4M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Pitney Bowes's Piotroski F-Score?

Pitney Bowes (PBI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Pitney Bowes's earnings high quality?

Pitney Bowes (PBI) has an earnings quality ratio of 2.65x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Pitney Bowes?

Pitney Bowes (PBI) scores 14 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.